GLP1R and thyroid gland carcinoma: Point estimates in that study were of similar magnitude for duration of drug use <1 year, 1-3 years, and >3 years.7 Given that a potential effect of GLP1 receptor agonists on thyroid cancer is unlikely to emerge after short term use, these findings might indicate the presence of confounding.